In addition, it has been reported that the low expression of UGP2 is significantly correlated with the fatty acid metabolism and related to fatty acid metabolic enzymes such as FAS, so it is speculated that UGP2 may play an important role in the occurrence and development of liver diseases by regulating the metabolism of fatty acid (Hu et al., 2020). This evidence concerns the gene FAS and liver disorder.